Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Case Report Volume 3 Issue 10

Transient Blindness due to Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient of Beta-thalassemia Major

Muhtamim Chowdhury1, Purushuttom Baniya1, Vijay Kumar Raut1, Fahtiha Nasreen2, Tonazzina Hossain Sauda3, Zakia Jabin Loskor4, Md Moshiur Rahman5* and Asifur Rahman1

1Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University, Bangladesh
2Department of Orthopedic Surgery and Traumatology, Armed Forces Medical College, Bangladesh
3Department of Internal Medicine, Bangladesh Medical College, Bangladesh
4Department of Gynaecology and Obstetrics, Central Hospital, Bangladesh
5Department of Neurosurgery, Holy Family Red Crescent Medical College Hospital, Bangladesh

*Corresponding Author: Md Moshiur Rahman, Department of Neurosurgery, Holy Family Red Crescent Medical College Hospital, Dhaka, Bangladesh.

Received: August 14, 2020; Published: September 07, 2020



  Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical but mostly radiological diagnosis with a wide variety of etiologies that is commonly underdiagnosed and missed due to the complete reversibility of its course. The pathophysiology lies in the raised blood pressure that disrupts the internal autoregulation within brain. Ours is a patient who presented as such, is a diagnosed case of B-thalassemia major. One previous author reported of PRES in gravid women with abnormal blood picture which being a rarity interested us in reporting this case [1]. Diagnosis now is more MR based but treatment yet remains elusive and mostly symptomatic.

Keywords: Posterior Reversible Encephalopathy Syndrome (PRES); Headache; Thalassemia; Transient Blindness



  1. Schwartz RB., et al. “Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy”. Radiology2 (2000): 371-376.
  2. Hinchey J., et al. “A Reversible Posterior Leukoencephalopathy Syndrome”. The New England Journal of Medicine 8 (1996): 494-500.
  3. Hagemann G., et al. “Recurrent posterior reversible encephalopathy syndrome (PRES)”. Journal of Human Hypertension 4 (2004): 287-289.
  4. Moawad FJ., et al. “Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose”. Southern Medical Journal 5 (2006): 511-514.
  5. Stevens T., et al. “Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut”. Vol. 142, Annals of internal medicine. United States (2005): 477-478.
  6. Khan SJ., et al. “Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings”. Journal of Global Oncology 4 (2018): 1-8.
  7. Ay H., et al. “Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI”. Neurology5 (1998): 1369-1376.
  8. Edvinsson L., et al. “Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study”. Brain Research3 (1976): 377-393.
  9. Schwartz RB., et al. “Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis”. American Journal of Neuroradiology 5 (1998): 859-862.
  10. Morello F., et al. “Hypertensive brain stem encephalopathy: clinically silent massive edema of the pons”. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 4 (2001): 317-320.
  11. Mirzamoradi M., et al. “Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Eclampsia: A Case Study”. International Journal of Medical Research and Health Sciences 3 (2017): 48-53.
  12. Faille L della., et al. “Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome”. Acta Neurologica Belgica 2 (2017): 469-475.
  13. Hartmann H. “Posterior Reversible Encephalopathy: An Epileptic Syndrome?”. Neuropediatrics 2 (2017): 064-065.
  14. López-García F., et al. “A reversible posterior leukoencephalopathy syndrome”. Review Neurology3 (2004): 261-266.
  15. Doelken M., et al. “Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI”. Diagnostic and Interventional Radiology 3 (2007): 125-128.
  16. Ait S., et al. “Cortical blindness and posterior reversible encephalopathy syndrome in an older patient”. BMJ Case Report (2012).
  17. Fuseau Herrera M., et al. “Diagnosis and management of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus. Case report”. Revista Colombiana de Reumatología 1 (2019): 74-79.
  18. Garg RK. Posterior leukoencephalopathy syndrome”. Postgraduate Medical Journal 903 (2001): 24-28.
  19. Prasad N., et al. “Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?” Pediatric Nephrology 11 (2003): 1161-1166.
  20. Roth C and Ferbert A. “Posterior reversible encephalopathy syndrome: long-term follow-up”. Journal of Neurology, Neurosurgery, and Psychiatry 7 (2010): 773-777.


Citation: Md Moshiur Rahman., et al. “Transient Blindness due to Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient of Beta-thalassemia Major".Acta Scientific Neurology 3.10 (2020): 02-06.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US